Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Feb;87(2):513–518. doi: 10.1172/JCI115025

Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.

A T Van der Ploeg 1, M A Kroos 1, R Willemsen 1, N H Brons 1, A J Reuser 1
PMCID: PMC296338  PMID: 1991835

Abstract

The lysosomal storage disorder glycogenosis type II is caused by acid alpha-glucosidase deficiency. In this study we have investigated the possible applicability of mannose 6-phosphate receptor-mediated enzyme replacement therapy to correct the enzyme deficiency in the most affected tissues. Bovine testes acid alpha-glucosidase containing phosphorylated mannose residues was intravenously administered to mice and found to be taken up by heart (70% increase of activity) and skeletal muscle (43% increase); the major target organs. The uptake of nonphosphorylated human placenta acid alpha-glucosidase by heart and skeletal muscle appeared to be significantly less efficient, whereas uptake of dephosphorylated bovine testes enzyme was not detectable. The phosphorylated bovine testes acid alpha-glucosidase remained present in mouse skeletal muscle up to 9-15 d after administration, with a half-life of 2-4 d. Besides being measured in skeletal muscle and heart, uptake of phosphorylated bovine testes and nonphosphorylated human placenta acid alpha-glucosidase was measured in several other organs, but not in brain. The increase of acid alpha-glucosidase activity was highest in liver and spleen. We concluded that application of mannose 6-phosphate receptor-mediated enzyme replacement therapy may offer new perspectives for treatment of glycogenesis type II.

Full text

PDF
513

Images in this article

515Image
on p.515
516Image
on p.516

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achord D. T., Brot F. E., Bell C. E., Sly W. S. Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells. Cell. 1978 Sep;15(1):269–278. doi: 10.1016/0092-8674(78)90102-2. [DOI] [PubMed] [Google Scholar]
  2. Achord D., Brot F., Gonzalez-Noriega A., Sly W., Stahl P. Human beta-glucuronidase. II. Fate of infused human placental beta-glucuronidase in the rat. Pediatr Res. 1977 Jul;11(7):816–822. doi: 10.1203/00006450-197707000-00008. [DOI] [PubMed] [Google Scholar]
  3. BAUDHUIN P., HERS H. G., LOEB H. AN ELECTRON MICROSCOPIC AND BIOCHEMICAL STUDY OF TYPE II GLYCOGENOSIS. Lab Invest. 1964 Sep;13:1139–1152. [PubMed] [Google Scholar]
  4. Barton N. W., Furbish F. S., Murray G. J., Garfield M., Brady R. O. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1913–1916. doi: 10.1073/pnas.87.5.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brady R. O., Tallman J. F., Johnson W. G., Gal A. E., Leahy W. R., Quirk J. M., Dekaban A. S. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease. N Engl J Med. 1973 Jul 5;289(1):9–14. doi: 10.1056/NEJM197307052890103. [DOI] [PubMed] [Google Scholar]
  6. Brot F. E., Bell C. E., Jr, Sly W. S. Purification and properties of beta-glucuronidase from human placenta. Biochemistry. 1978 Feb 7;17(3):385–391. doi: 10.1021/bi00596a001. [DOI] [PubMed] [Google Scholar]
  7. Dean M. F., Muir H., Benson P. F., Button L. R., Batchelor J. R., Bewick M. Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome. Nature. 1975 Oct 16;257(5527):609–612. doi: 10.1038/257609a0. [DOI] [PubMed] [Google Scholar]
  8. Desnick R. J., Thorpe S. R., Fiddler M. B. Toward enzyme therapy for lysosomal storage diseases. Physiol Rev. 1976 Jan;56(1):57–99. doi: 10.1152/physrev.1976.56.1.57. [DOI] [PubMed] [Google Scholar]
  9. Di Ferrante N., Nichols B. L., Donnelly P. V., Neri G., Hrgovcic R., Berglund R. K. Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion. Proc Natl Acad Sci U S A. 1971 Feb;68(2):303–307. doi: 10.1073/pnas.68.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harris R. E., Hannon D., Vogler C., Hug G. Bone marrow transplantation in type IIa glycogen storage disease. Birth Defects Orig Artic Ser. 1986;22(1):119–132. [PubMed] [Google Scholar]
  11. Hickman S., Shapiro L. J., Neufeld E. F. A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts. Biochem Biophys Res Commun. 1974 Mar 15;57(1):55–61. doi: 10.1016/s0006-291x(74)80356-6. [DOI] [PubMed] [Google Scholar]
  12. Hobbs J. R. Displacement bone marrow transplantation and immunoprophylaxis for genetic diseases. Adv Intern Med. 1988;33:81–118. [PubMed] [Google Scholar]
  13. Hobbs J. R. Experience with bone marrow transplantation for inborn errors of metabolism. Enzyme. 1987;38(1-4):194–206. doi: 10.1159/000469205. [DOI] [PubMed] [Google Scholar]
  14. Hoefsloot L. H., Hoogeveen-Westerveld M., Kroos M. A., van Beeumen J., Reuser A. J., Oostra B. A. Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J. 1988 Jun;7(6):1697–1704. doi: 10.1002/j.1460-2075.1988.tb02998.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Howell J. M., Dorling P. R., Dimarco P. N., Taylor E. G. Multiple implantation of normal amnion into cattle with generalized glycogenosis type II. J Inherit Metab Dis. 1987;10(1):3–10. doi: 10.1007/BF01799481. [DOI] [PubMed] [Google Scholar]
  16. Kaplan A., Achord D. T., Sly W. S. Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc Natl Acad Sci U S A. 1977 May;74(5):2026–2030. doi: 10.1073/pnas.74.5.2026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kiess W., Blickenstaff G. D., Sklar M. M., Thomas C. L., Nissley S. P., Sahagian G. G. Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor. J Biol Chem. 1988 Jul 5;263(19):9339–9344. [PubMed] [Google Scholar]
  18. Knudson A. G., Jr, Di Ferrante N., Curtis J. E. Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1738–1741. doi: 10.1073/pnas.68.8.1738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Lagunoff D., Nicol D. M., Pritzi P. Uptake of beta-glucuronidase by deficient human fibroblasts. Lab Invest. 1973 Oct;29(4):449–453. [PubMed] [Google Scholar]
  22. Mehler M., DiMauro S. Residual acid maltase activity in late-onset acid maltase deficiency. Neurology. 1977 Feb;27(2):178–184. doi: 10.1212/wnl.27.2.178. [DOI] [PubMed] [Google Scholar]
  23. Morgan D. O., Edman J. C., Standring D. N., Fried V. A., Smith M. C., Roth R. A., Rutter W. J. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature. 1987 Sep 24;329(6137):301–307. doi: 10.1038/329301a0. [DOI] [PubMed] [Google Scholar]
  24. Mutsaers J. H., Van Halbeek H., Vliegenthart J. F., Tager J. M., Reuser A. J., Kroos M., Galjaard H. Determination of the structure of the carbohydrate chains of acid alpha-glucosidase from human placenta. Biochim Biophys Acta. 1987 Jan 30;911(2):244–251. doi: 10.1016/0167-4838(87)90014-8. [DOI] [PubMed] [Google Scholar]
  25. Neufeld E. F., Cantz M. J. Corrective factors for inborn errors of mucopolysaccharide metabolism. Ann N Y Acad Sci. 1971 Jul 6;179:580–587. doi: 10.1111/j.1749-6632.1971.tb46934.x. [DOI] [PubMed] [Google Scholar]
  26. Rattazzi M. C., Lanse S. B., McCullough R. A., Nester J. A., Jacobs E. A. Towards enzyme replacement in GM2 gangliosidosis: organ disposition and induced central nervous system uptake of human beta-hexosaminidase in the cat. Birth Defects Orig Artic Ser. 1980;16(1):179–193. [PubMed] [Google Scholar]
  27. Reuser A. J., Koster J. F., Hoogeveen A., Galjaard H. Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet. 1978 Mar;30(2):132–143. [PMC free article] [PubMed] [Google Scholar]
  28. Reuser A. J., Kroos M. A., Ponne N. J., Wolterman R. A., Loonen M. C., Busch H. F., Visser W. J., Bolhuis P. A. Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients. Exp Cell Res. 1984 Nov;155(1):178–189. doi: 10.1016/0014-4827(84)90779-1. [DOI] [PubMed] [Google Scholar]
  29. Reuser A. J., Kroos M., Oude Elferink R. P., Tager J. M. Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. J Biol Chem. 1985 Jul 15;260(14):8336–8341. [PubMed] [Google Scholar]
  30. Reuser A. J., Kroos M., Willemsen R., Swallow D., Tager J. M., Galjaard H. Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. J Clin Invest. 1987 Jun;79(6):1689–1699. doi: 10.1172/JCI113008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ringdén O., Groth C. G., Erikson A., Bäckman L., Granqvist S., Månsson J. E., Svennerholm L. Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease. Transplantation. 1988 Jul;46(1):66–70. doi: 10.1097/00007890-198807000-00011. [DOI] [PubMed] [Google Scholar]
  32. Sando G. N., Neufeld E. F. Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts. Cell. 1977 Nov;12(3):619–627. doi: 10.1016/0092-8674(77)90262-8. [DOI] [PubMed] [Google Scholar]
  33. Scaggiante B., Pineschi A., Sustersich M., Andolina M., Agosti E., Romeo D. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation. 1987 Jul;44(1):59–61. doi: 10.1097/00007890-198707000-00014. [DOI] [PubMed] [Google Scholar]
  34. Schlesinger P., Rodman J. S., Frey M., Lang S., Stahl P. Clearance of lysosomal hydrolases following intravenous infusion. The role of liver in the clearance of beta-glucuronidase and N-acetyl-beta-D-glucosaminidase. Arch Biochem Biophys. 1976 Dec;177(2):606–614. doi: 10.1016/0003-9861(76)90472-0. [DOI] [PubMed] [Google Scholar]
  35. Stahl P., Six H., Rodman J. S., Schlesinger P., Tulsiani D. R., Touster O. Evidence for specific recognition sites mediating clearance of lysosomal enzymes in vivo. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4045–4049. doi: 10.1073/pnas.73.11.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tager J. M., Hamers M. N., Schram A. W., Van den Bergh F. A., Rietra P. J., Loonen C., Koster J. F., Slee R. An appraisal of human trials in enzyme replacement therapy of genetic diseases. Birth Defects Orig Artic Ser. 1980;16(1):343–359. [PubMed] [Google Scholar]
  37. Tong P. Y., Tollefsen S. E., Kornfeld S. The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II. J Biol Chem. 1988 Feb 25;263(6):2585–2588. [PubMed] [Google Scholar]
  38. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Van der Ploeg A. T., Loonen M. C., Bolhuis P. A., Busch H. M., Reuser A. J., Galjaard H. Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle. Pediatr Res. 1988 Jul;24(1):90–94. doi: 10.1203/00006450-198807000-00021. [DOI] [PubMed] [Google Scholar]
  40. Watson J. G., Gardner-Medwin D., Goldfinch M. E., Pearson A. D. Bone marrow transplantation for glycogen storage disease type II (Pompé's disease) N Engl J Med. 1986 Feb 6;314(6):385–385. doi: 10.1056/nejm198602063140611. [DOI] [PubMed] [Google Scholar]
  41. Willemsen R., Wisselaar H. A., van der Ploeg A. T. Plasmalemmal vesicles are involved in transendothelial transport of albumin, lysosomal enzymes and mannose 6-phosphate receptor fragments in capillary endothelium. Eur J Cell Biol. 1990 Apr;51(2):235–241. [PubMed] [Google Scholar]
  42. de Barsy T., Jacquemin P., Van Hoof F., Hers H. G. Enzyme replacement in Pompe disease: an attempt with purified human acid alpha-glucosidase. Birth Defects Orig Artic Ser. 1973 Mar;9(2):184–190. [PubMed] [Google Scholar]
  43. de Jonge A. J., de Smit S., Kroos M. A., Reuser A. J. Cotransfer of syntenic human genes into mouse cells using isolated metaphase chromosomes or cellular DNA. Hum Genet. 1985;69(1):32–38. doi: 10.1007/BF00295526. [DOI] [PubMed] [Google Scholar]
  44. van Diggelen O. P., Hoogeveen A. T., Smith P. J., Reuser A. J., Galjaard H. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency. Biochim Biophys Acta. 1982 Apr 21;703(1):69–76. doi: 10.1016/0167-4838(82)90012-7. [DOI] [PubMed] [Google Scholar]
  45. van Ewijk W., Verzijden J. H., van der Kwast T. H., Luijcx-Meijer S. W. Reconstitution of the thymus dependent area in the spleen of lethally irradiated mice. A light and electron microscopical study of the T-cell microenvironment. Cell Tissue Res. 1974;149(1):43–60. doi: 10.1007/BF00209049. [DOI] [PubMed] [Google Scholar]
  46. van der Ploeg A. T., Bolhuis P. A., Wolterman R. A., Visser J. W., Loonen M. C., Busch H. F., Reuser A. J. Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells. J Neurol. 1988 Sep;235(7):392–396. doi: 10.1007/BF00314479. [DOI] [PubMed] [Google Scholar]
  47. van der Ploeg A. T., Kroos M., van Dongen J. M., Visser W. J., Bolhuis P. A., Loonen M. C., Reuser A. J. Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidase. J Neurol Sci. 1987 Jul;79(3):327–336. doi: 10.1016/0022-510x(87)90239-5. [DOI] [PubMed] [Google Scholar]
  48. van der Ploeg A. T., van der Kraaij A. M., Willemsen R., Kroos M. A., Loonen M. C., Koster J. F., Reuser A. J. Rat heart perfusion as model system for enzyme replacement therapy in glycogenosis type II. Pediatr Res. 1990 Oct;28(4):344–347. doi: 10.1203/00006450-199010000-00009. [DOI] [PubMed] [Google Scholar]
  49. von Figura K., Hasilik A. Lysosomal enzymes and their receptors. Annu Rev Biochem. 1986;55:167–193. doi: 10.1146/annurev.bi.55.070186.001123. [DOI] [PubMed] [Google Scholar]
  50. von Specht B. U., Geiger B., Arnon R., Passwell J., Keren G., Goldman B., Padeh B. Enzyme replacement in Tay-Sachs disease. Neurology. 1979 Jun;29(6):848–854. doi: 10.1212/wnl.29.6.848. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES